Lung cancer remains the most common cancer in Hong Kong. As a leading cancer killer worldwide, its treatment still needs...
Researchers in Asia are increasingly evaluating the significance and scope of proteomics in biomolecular discovery effor...
A team of researchers from the National University of Singapore (NUS) led by Assistant Professor Cheow Lih Feng from the...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General Hospital (S...
The Hong Kong Science and Technology Parks Corporation (HKSTP, a public corporation set up by the Hong Kong Government) ...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...
In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting&rsquo...
The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) led a team of a dozen international...
Singapore based startup CytoMed Therapeutics, spun off from the Agency for Science, Technology and Research (A*STAR), ha...
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...
A ground-breaking clinical trial involving microbiome transfer to alleviate gut problems in Autistic people is starting ...
A Hong Kong Baptist University (HKBU) collaborative research team has shown that urine tests for human cytomegalovirus (...
Can you explain what GPCR heteromers are and why they are a promising target for cancer therapeutics? Before I answer y...
A key goal for any innovative cancer treatment is the ability to deliver an anti-cancer agent directly to the tumour and...
MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufac...
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...
Scientists from A*STAR’s Genome Institute of Singapore (GIS) have ascertained that there is no stable microbial co...
South Korea-based firms Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agre...
Researchers from The University of Technology Sydney (UTS), Australia have demonstrated that 3D bioprinted heart tissues...
A thin, flexible gold sensor engineered at The University of Queensland (UQ), Australia has the potential to unlock the ...
Three research teams from the Singapore-MIT Alliance for Research and Technology (SMART) – MIT’s r...
Brain tissue grown in a laboratory by University of Queensland (UQ) researchers in Australia will be used to test a trea...
US-based Virginia Commonwealth University's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has announc...
Scientists at the University of Sydney, Australia with collaborators from Australia, South Korea and China. have devel...
Cancer is a leading cause of death worldwide, accounting for approximately one in six deaths, with metastatic ...
$5.7 million in research grants has been awarded to four projects aiming to foster research partnerships between institu...
Singapore-headquartered biopharmaceutical company Specialised Therapeutics Asia (ST) will partner with CTTQ-Akeso (Shang...
Chula Medicine researchers in Thailand have successfully published an article on the injection of patient's own platelet...
University of Otago researchers in New Zealand have discovered new ways to treat antibiotic-resistant strains of tubercu...
Tuberculosis (TB) patients can look forward to a much-shortened treatment period, compared to the current six-month trea...
JDRF Australia and funding partner The Leona M. and Harry B. Helmsley Charitable Trust have announced a combined additio...
Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy met...
A research team from South Korea-based Pohang University of Science and Technology (POSTECH) collaborated with researche...
Australia's University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sep...
Australia-based Griffith University’s world-first study into cell transplantation to repair injuries to the nervou...
A novel drug is showing promise for alleviating heart failure, a common condition associated with sleep apnoea and a red...
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. The result...
Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...
In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...
Epilepsy affects over 150,000 Australians, and 50 million globally, with one-third struggling to control their condition...
A newly discovered “energy switch” in the immune cells of the brain may lead to the development of drugs for...
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...
Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lifespan of o...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for...
Please share more details about the technology that has been transferred by Olink to NUS? What is so unique...
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medi...
Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...
Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...
South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...
Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...
Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...
Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...
What is Anticancer Bioscience’s competitive edge and what is unique about the pipeline you are developing?&n...
Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...
In a world first, scientists at Duke-NUS Medical School, the National Heart Centre Singapore (NHCS) and colleagues in ...
Scientists at the University of Sydney, Australia have been awarded $1.7 million from New South Wales Ministry ...
According to the scientists at Thai Red Cross Emerging Infectious Diseases Health Science Center, Faculty of Medicine,&n...
The age-old quest for immortality has taken a step forward with the results of a New Zealand study recently published by...
GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, has entered into a ...
ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...
Ferronova has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeon...
Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...
After a heart attack, the shock of the event leaves behind a trail of damaged heart muscle, which becomes a scar over ti...
How crucial is the adaptation of next-generation TCR cell therapies for diagnostic and prophylactic purposes? TCR cell ...
An option and research collaboration agreement has been established between Australia's Monash University and Japan-base...
Malaysian Genomics Resource Centre Berhad , a leading genomics and biopharmaceutical specialist, has announced a s...
Singapore’s drug discovery efforts have reached a new milestone as EBC-129, the first made-in-Singapore antibody-d...
With biomarkers and biotherapeutics gaining significant attention in 2022, BioSpectrum spoke in detail with Jason Neo (R...
Scientists are now using patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of ...
Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...
Singapore researchers have discovered a novel therapeutic target named ADAM10 that could be used to treat patients ...
A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...
A recent study by a team comprising researchers from the National University of Singapore (NUS) and the National Univers...
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone amabolic therapies...
Eisai and Washington University School of Medicine in St. Louis have entered into a comprehensive research collaboration...
A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...
Scientists at Duke-NUS Medical School in Singapore have identified a gene that controls the behaviour of a specific type...
A Hong Kong Baptist University (HKBU) collaborative research team, along with researchers at Hong Kong Polytechnic ...
According to the Department of Statistics Malaysia (DOSM), population with age 60 and above is increasing yearly and Mal...
Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...
The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New P...
Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...
A new University of Auckland spin-out company, TheiaNova, is working to introduce a groundbreaking, non-invasive treatme...
Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...
A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...
How would you describe your primary mission and vision of the Centre for Microbiome Medicine? Microbiome is the l...
JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...
The winner of this year's pre-eminent research award in the Faculty of Medical and Health Sciences, Professor Michael (M...
Nanyang Technological University (NTU) Singapore scientists have found that a stress response in cells, when ‘swit...
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...
South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...
An immunity research study has found that the previously identified disease-associated microglia (DAM) population d...
The Australian government is providing almost $700,000 to fund new research investigating the impact of endometriosis on...
According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes ...
Australia based AdAlta Limited, the clinical stage drug discovery company and South Korea based GPCR Therapeutics Inc, a...
